Effect of epigallocatechin-3-gallate on inflammatory mediators release in LPS-induced Parkinson's disease in rats

Indian Journal of Experimental Biology

Volumn 51, Issue 5, 2013, Pages 357-362

  AL amri, Jehan S ^a   Hagras, Magda M ^a,b   Mujallid, Mohamed I ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b SUEZ CANAL UNIVERSITY   (Egypt)

Author keywords

Epigallocatechin 3 gallate; Lipopolysaccharide; Nitric oxide; Parkinson's disease; TNF

Indexed keywords

AUTACOID; CATECHIN; DOPAMINE; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; MALE; METABOLISM; PARKINSONISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CATECHIN; DOPAMINE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84877284200     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mayeux R, Epidemiology of neurodegeneration, Annu Rev Neurosci, 26 (2003) 81.
2. Pabon MM, Bachstetter AD, Hudson CE, Gemma C & Bickford PC, CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease, J Neuroinflammation, 8 (2011) 9.
3. Kreutzberg GW, Microglia: a sensor for pathological events in the CNS, Trends Neurosci, 19 (1996) 312.
4. Shibata N & Kobayashi M, The role for oxidative stress in neurodegenerative diseases, Brain Nerve, 60 (2008) 157.
5. Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL & Hong JS, Role of nitric oxide in inflammation-mediated neurodegeneration, Ann N Y Acad Sci, 962 (2002) 318.
6. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B & Hong JS, Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia, J Neurosci, 20 (2000) 6309.
7. Gibbons HM & Dragunow M, Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide, Brain Res, 1084 (2006) 1.
8. Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ & Lee VM, Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration, J Neurosci, 28 (2008) 7687.
9. Nihal M, Ahsan H, Siddiqui IA, Mukhtar H, Ahmad N & Wood GS, (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma, Cell Cycle, 8 (2009) 2057.
10. Nagle DG, Ferreira D & Zhou YD, Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives, Phytochemistry, 67 (2006) 1849.
11. Shimojo N, Jesmin S, Zaedi S, Maeda S, Gando S, Yamaguchi I, Goto K & Miyauchi T, Alterations of gene expressions of preproET-1 and ET receptors in brains of endotoxemic Sprague-Dawley rats, Exp Biol Med (Maywood), 231 (2006) 1058.
12. Rasoolijazi H, Joghataie MT, Roghani M & Nobakht M, The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis, Iran Biomed J, 11 (2007) 237.
13. Andersson M, Konradi C & Cenci MA, cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopaminedenervated striatum, J Neurosci, 21 (2001) 9930.
14. Ware CF, Vanarsdale S & Vanarsdale TL, Apoptosis mediated by the TNF-related cytokine and receptor families, J Cell Biochem, 60 (1996) 47.
15. Moncada, S, The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway, Acta Physiol Scand, 145 (1992) 201.
16. Souza BR, Romano-Silva MA & Tropepe V, Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae, J NeuroSci, 31 (2011) 5512.
17. Liu B, Jiang JW, Wilson BC, Du L, Yang SN, Wang JY, Wu G C, Cao X D & Hong J S, Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide, J Pharmacol Exp Ther, 295 (2000) 125.
18. Block ML & Hong JS, Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism, Prog Neurobiol, 76 (2005) 77.
19. Herrera AJ, Castaño A, Venero JL, Cano J, Machado A, The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system, Neurobiol Dis, 7 (2000) 429.
20. L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Impagnatiello F, Impagnatiello F & Marchetti B, Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice, Rejuvenation, 14 (2011) 411.
21. Singh AK & Jiang Y, How does peripheral lipopolysaccharide induce gene expression in the brain of rats?, Toxicology, 201 (2004) 197.
22. Qian L, Tan KS, Wei SJ, Wu HM, Xu Z, Wilson B, Lu R B, Hong J S & Flood P M, Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptorindependent reduction of NADPH oxidase activity, J Immunol, 179 (2007) 1198.
23. Mayhan WG, Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier, Brain Res, 743 (1996) 70.
24. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA & Kastin AJ, Tumor necrosis factor-alpha: a neuromodulator in the CNS, Neurosci Biobehav Rev, 21 (1997) 603.
25. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp D J & Crews F T, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55 (2007) 453.
26. Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM & Carvey PM, Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain, Neuroscience, 124 (2004) 619.
27. Jung JY, Han CR, Jeong YJ, Kim HJ, Lim HS, Lee KH, Park H O, OH W M, Kim S H & Kim W J, Epigallocatechin gallate inhibits nitric oxide-induced apoptosis in rat PC12 cells, Neurosci Lett, 411 (2007) 222.
28. Lee SF, Huang YT, Wu WS & Lin JK, Induction of c-jun protooncogene expression by hydrogen peroxide through hydroxyl radical generation and p60SRC tyrosine kinase activation, Free Radic Biol Med, 21 (1996) 437.
29. Bastian NR & Hibbs JB Jr, Assembly and regulation of NADPH oxidase and nitric oxide synthase, Curr Opin Immunol, 6 (1994) 131.
30. Karin M & Ben-Neriah Y, Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity, Annu Rev Immunol, 18 (2000) 621.
31. Lin YL & Lin JK, (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB, Mol Pharmacol 52 (1997) 465.
32. Choi JY, Park CS, Kim DJ, Cho MH, Jin BK, Pie JE & Chung W G, Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate, Neurotoxicology, 23 (2002) 367.
33. Lee H, Bae JH & Lee SR, Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils, J Neurosci Res, 77 (2004) 892.
34. Pan T, Fei J, Zhou X, Jankovic J & Le W, Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury, Life Sci, 72 (2003) 1073.